YOLFTbeta
ZhuZhou QianJin Pharmaceutical Co Ltd

ZhuZhou QianJin Pharmaceutical Co Ltd

600479 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

10.37CNY-0.39 (-3.62%)

Price History

Full chart

Market Stats

Previous Close10.76
Open10.70
Day Range10.31 – 10.77
52-Week Range8.90 – 15.25
Volume16.57M
Market Cap6.10B
P/E (TTM)16.99
Forward P/E26.74
EPS0.73
Dividend Yield3.06%
Beta0.25
50-Day Avg11.20
200-Day Avg10.62

About

ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 and is headquartered in Zhuzhou, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Zhiyong Chen
  • Employees5.04K
  • HeadquartersNo. 801 Zhuzhou Avenue, Zhuzhou, China, 412000, China
  • Websitehttps://www.qjyy.com

Leadership

  • Mr. Zhiyong ChenGeneral Manager · b. 1977
  • Ms. Yunjiao OuyangDeputy General Manager · b. 1972
  • Ms. Li ZhuBoard secretary · b. 1977
  • Mr. Aiwei XieDeputy General Manager · b. 1968
  • Mr. Yun GongDeputy General Manager · b. 1969
  • Ms. Yihua PengDeputy General Manager · b. 1973
  • Zhouyang WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue560.21M582.03M686.80M604.93M665.83M602.69M679.78M801.43M904.27M979.44M1.26B1.58B1.97B2.19B2.45B2.86B3.18B3.33B3.53B3.63B3.66B4.03B3.80B3.63B3.63B
Growth (%)-+3.89%+18.00%-11.92%+10.07%-9.48%+12.79%+17.90%+12.83%+8.31%+28.29%+26.02%+24.59%+11.22%+11.50%+17.09%+11.09%+4.58%+5.91%+2.89%+1.02%+9.89%-5.66%-4.44%+0.13%
Cost of Revenue417.28M405.90M476.10M409.40M423.79M309.37M322.31M345.79M360.83M427.85M603.54M791.08M1.01B1.15B1.32B1.58B1.75B1.78B1.92B2.04B2.04B2.30B2.05B1.95B1.86B
Gross Profit142.94M176.13M210.70M195.53M242.03M293.32M357.47M455.64M543.44M551.59M652.99M792.35M957.90M1.04B1.13B1.29B1.43B1.55B1.60B1.59B1.63B1.73B1.75B1.68B3.63B
Gross Margin25.51%30.26%30.68%32.32%36.35%48.67%52.59%56.85%60.10%56.32%51.97%50.04%48.55%47.60%46.07%44.97%45.05%46.45%45.48%43.81%44.38%42.98%46.02%46.25%100.00%
Operating Expense91.03M115.90M139.24M140.28M167.76M209.44M158.58M312.58M388.20M450.06M544.90M659.52M807.92M913.99M1.03B1.09B1.14B1.21B1.17B1.16B1.19B1.29B1.29B1.35B3.19B
Operating Income51.90M60.23M71.47M55.26M74.27M83.88M198.89M143.05M155.24M101.53M108.08M132.83M149.99M130.41M94.76M193.95M296.35M337.39M430.78M424.18M436.23M444.25M461.94M332.11M440.51M
Operating Margin9.26%10.35%10.41%9.13%11.15%13.92%29.26%17.85%17.17%10.37%8.60%8.39%7.60%5.94%3.87%6.77%9.31%10.14%12.22%11.70%11.91%11.03%12.16%9.15%12.12%
EBITDA50.02M73.44M90.71M79.53M97.81M109.64M95.49M132.15M165.10M150.02M148.12M193.46M205.25M195.04M166.48M260.63M351.92M414.87M491.19M488.39M503.49M521.27M547.13M419.97M514.55M
EBITDA Margin8.93%12.62%13.21%13.15%14.69%18.19%14.05%16.49%18.26%15.32%11.79%12.22%10.40%8.89%6.80%9.10%11.06%12.46%13.93%13.47%13.74%12.95%14.40%11.57%14.16%
Net Income34.49M39.75M50.07M45.39M59.86M71.78M173.62M129.89M130.91M86.38M82.82M120.16M123.77M105.09M92.96M149.43M207.76M255.36M294.31M297.07M302.06M302.51M320.41M230.76M287.84M
Net Income Margin6.16%6.83%7.29%7.50%8.99%11.91%25.54%16.21%14.48%8.82%6.59%7.59%6.27%4.79%3.80%5.22%6.53%7.67%8.35%8.19%8.24%7.51%8.44%6.36%7.92%
R&D---------10.61M14.64M32.98M36.79M48.23M64.69M61.86M78.80M84.09M105.36M104.06M108.72M113.82M149.07M220.20M185.60M
R&D as % of Total Revenue---------1.08%1.17%2.08%1.86%2.20%2.64%2.16%2.48%2.53%2.99%2.87%2.97%2.83%3.92%6.07%5.11%
Interest Expense276.77K1.08M2.26M1.18M139.15K1.05M724.11K345080.69K186.79K2.14M4.15M6.14M6.52M4.07M2.59M747.25K416.40K2.92M5.83M6.43M5.96M8.47M52.97K
Interest Expense % of Total Revenue0.05%0.19%0.33%0.20%0.02%0.17%0.11%0.00%0.00%0.01%0.01%0.14%0.21%0.28%0.27%0.14%0.08%0.02%0.01%0.08%0.16%0.16%0.16%0.23%0.00%

Balance Sheet

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets332.78M359.87M421.29M792.53M798.23M828.73M1.09B1.06B1.27B1.13B1.28B1.65B1.89B2.23B2.74B3.03B3.29B3.47B3.81B4.23B4.06B4.62B4.68B4.56B4.96B
Total Liabilities182.84M174.31M188.23M148.38M203.38M169.13M189.30M183.66M314.48M188.65M288.10M581.18M683.92M843.20M779.17M948.21M1.05B1.04B1.18B1.47B1.36B1.82B1.65B1.42B1.61B
Total Equity135.39M165.82M216.93M630.62M578.49M640.58M874.64M851.40M924.03M901.57M908.29M966.04M1.01B1.12B1.65B1.75B1.88B2.03B2.18B2.27B2.15B2.22B2.39B2.46B3.03B
Cash93.20M72.86M71.31M377.49M404.35M400.79M397.36M507.24M184.88M274.62M119.18M150.68M183.16M227.41M513.22M728.40M508.07M991.13M1.38B755.37M632.88M1.24B2.00B1.34B780.15M
Total Debt1.52M32.80M33.10M12.00M670.26K670.26K670.26K670.26K131.00M670.26K670.26K115.90M87.00M93.00M57.11M47.80M38.30M27.70M22.44M196.89M148.93M124.24M116.71M433.04M-
Net Debt-91.68M-40.06M-38.21M-365.49M-403.68M-400.12M-396.69M-506.57M-53.88M-273.95M-118.51M-34.78M-96.16M-134.41M-456.11M-680.60M-469.77M-963.43M-1.36B-558.49M-483.95M-1.12B-1.88B-911.44M-

Cash Flow

Currency: CNY2001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.07M50.96M18.45M76.50M120.12M79.26M37.20M73.54M39.13M22.58M197.82M137.63M183.34M67.48M140.88M283.47M383.47M155.49M542.37M485.57M733.47M443.12M398.77M480.24M
Investing Cash Flow--62.23M-32.48M-57.79M-10.31M-26.35M-45.28M154.13M-471.49M273.26M-136.96M-224.74M-33.33M-111.78M-248.49M120.55M-417.78M275.00M176.30M-961.55M-43.34M122.15M585.29M-741.18M-
Financing Cash Flow-35.81M-20.03M345.52M-39.34M-97.33M-37.41M-81.46M69.07M-216.13M-41.07M56.21M-80.00M-52.80M448.37M-64.98M-93.60M-124.72M-180.72M-104.24M-520.58M-264.19M-202.00M-250.12M-
Capital Expenditure059.24M34.05M56.50M16.74M21.39M22.53M95.30M123.31M58.44M63.87M256.26M84.26M65.97M84.47M81.50M57.30M46.39M40.61M97.24M71.88M34.43M43.99M47.32M124.17M
Free Cash Flow--53.16M16.91M-38.04M59.76M98.73M56.73M-58.10M-49.76M-19.31M-41.30M-58.45M53.37M117.37M-16.99M59.38M226.16M337.07M114.88M445.14M413.69M699.04M399.13M351.45M356.08M
Dividends Paid-7.68M22.04M32.08M28.24M95.95M36.36M79.55M59.49M108.91M76.24M61.29M79.88M60.72M66.67M54.44M71.39M104.99M167.40M209.25M429.53M248.65M149.54M152.82M152.68M
FCF to OCF--875.22%33.19%-206.14%78.12%82.19%71.57%-156.17%-67.67%-49.36%-182.90%-29.55%38.78%64.02%-25.17%42.15%79.79%87.90%73.88%82.07%85.20%95.31%90.07%88.13%74.15%
Dividend Paid to FCF--14.44%130.34%-84.33%47.25%97.18%64.09%-136.93%-119.54%-563.87%-184.62%-104.86%149.65%51.74%-392.48%91.69%31.57%31.15%145.72%47.01%103.83%35.57%37.47%43.48%42.88%

Earnings

Report DateJun 3, 2009Aug 21, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Oct 26, 2010Mar 2, 2011Apr 23, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 24, 2013Aug 28, 2013Oct 29, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Mar 20, 2015Apr 29, 2015Jul 31, 2015Oct 30, 2015Mar 2, 2016Apr 27, 2016Aug 29, 2016Oct 28, 2016Feb 28, 2017Apr 28, 2017Aug 29, 2017Oct 27, 2017Apr 26, 2018Aug 22, 2018Oct 25, 2018Apr 22, 2019Aug 27, 2019Oct 29, 2019Apr 9, 2020Aug 28, 2020Oct 30, 2020Apr 29, 2021Aug 27, 2021Oct 28, 2021Apr 28, 2022Aug 26, 2022Oct 28, 2022Apr 29, 2023
EPS Estimate-0.11----0.12-0.14-------0.08-0.06--------------------------------
EPS Actual0.090.070.090.110.090.070.030.020.060.070.030.070.070.100.050.100.050.070.070.140.050.060.070.110.050.040.040.100.050.040.070.200.070.040.120.080.080.170.100.100.180.320.100.200.320.160.200.090.170.170.10
Surprise--36.36%-----75.00%--60.00%--------37.50%-16.67%--------------------------------
Timing-Pre-market----After-hours-Pre-market-------After-hours-After-hours----After-hoursPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-market---------

Key Statistics & Ratios

Market Cap6.10B
Enterprise Value5.94B
Trailing P/E16.99
Forward P/E26.74
Price / Sales1.64
Price / Book2.15
EPS0.73
Book Value6.14
Revenue (TTM)3.73B
Gross Profit (TTM)1.81B
EBITDA496.40M
Profit Margin9.10%
Operating Margin14.40%
Return on Equity12.34%
Return on Assets5.27%
Shares Outstanding492.21M
Shares Float314.01M
Beta0.25
Dividend Yield3.06%
Dividend Rate0.38
Payout Ratio101.26%

Dividends

20231×
0.35Jun 30, 2023
20221×
0.60Jun 21, 2022
20211×
1.00Jun 25, 2021
20201×
0.50Jun 17, 2020
20191×
0.40Jun 20, 2019
20181×
0.30Jun 15, 2018
20171×
0.17May 26, 2017
20161×
0.13Jul 1, 2016
20151×
0.17Jun 5, 2015
20141×
0.15Jul 16, 2014
20131×
0.21Jun 24, 2013
20121×
0.17Jun 26, 2012
20111×
0.21Jun 16, 2011
20101×
0.42Jun 9, 2010
20091×
0.19May 25, 2009
20081×
0.26Apr 25, 2008
20071×
0.11May 28, 2007
20062×
0.03Apr 24, 20060.32Jan 12, 2006
20051×
0.11Apr 26, 2005

Stock Splits

  • Jun 15, 20186:5
  • Jun 9, 20107:5
  • May 25, 20096:5
  • Apr 25, 20086:5
  • May 28, 20076:5
  • Apr 24, 20063:2
  • Apr 26, 20054997:3331